NCT06469125

Brief Summary

The Bladder Injury Classification System for Endoscopic Procedure (BICEP) is designed to provide a systematic framework for categorizing bladder injuries that occur during endoscopic procedures. By standardizing the classification of these injuries, BICEP promotes a more consistent approach to diagnosis, management, and prevention across different urologic interventions. This study aims to validate and implement the BICEP system during morcellation. This study will: Validate BICEP by using real-life clinical scenarios to ensure its applicability and effectiveness. Assess the incidence and types of bladder injuries during morcellation, using the BICEP categorization to standardize injury reporting and enhance treatment protocols.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2025

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 21, 2024

Completed
1.3 years until next milestone

Study Start

First participant enrolled

October 8, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 14, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 14, 2025

Completed
Last Updated

November 18, 2025

Status Verified

May 1, 2025

Enrollment Period

1 month

First QC Date

June 4, 2024

Last Update Submit

November 14, 2025

Conditions

Keywords

BICEP classificationAnatomic Endoscopic Enucleation of ProstateBladder InjuryHoLEPBiLEPThuFLEP

Outcome Measures

Primary Outcomes (2)

  • Number of Participants with Successful Validation of the Bladder Injury Classification System for Endoscopic Procedure Classification System for Bladder Injuries Occurring During Morcellation in AEEP Operations

    Approximately 250 participants will be evaluated using a scoring system ranging from 0 to 4 to assess the severity of the injury. A score of 0 indicates no injury, while a score of 4 indicates extensive avulsion of part of the bladder. In this system, the severity of the injury increases as the score increases.

    Up to 24 weeks

  • The impact of different energy sources and morcellation devices on bladder injury

    The severity of the injury will be assessed using a scoring system ranging from 0 to 4. A score of 0 indicates no injury, while a score of 4 indicates the highest degree of avulsion of part of the bladder. In this system, the severity of the injury increases as the score increases.

    Up to 24 weeks

Secondary Outcomes (4)

  • Postoperative Qmax Increase Following Morcellation in AEEP Operations

    1 month post surgery

  • Postoperative Improvement in International Prostate Symptom Score (IPSS)

    1 month post surgery

  • Duration of catheterization

    Up to 10 weeks

  • Length of hospital stay

    Up to 6 weeks

Interventions

The intervention in this study involves performing anatomic endoscopic enucleation of the prostate (AEEP) using different energy sources. Following the enucleation, the resected prostate tissue will be morcellated within the bladder using various morcellators to remove the enlarged prostate tissue minimally invasively. The process will also involve evaluating and categorizing any resulting bladder injuries using the BICEP classification system.

Also known as: Morcellation

Eligibility Criteria

Age40 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Participants will include adult patients undergoing AEEP surgery. The presence of bladder injuries during the operation will be assessed according to the BICEP classification, and any potential injuries will be recorded.

You may qualify if:

  • Patients aged ≥40
  • ASA (American Society of Anesthesiologists) score ≤4
  • Patients undergoing Holmium Laser Enucleation of the Prostate (HoLEP) or Transurethral Resection of the Prostate (TURP) surgery.

You may not qualify if:

  • Patients with neurological disorders that may affect bladder function, such as cerebrovascular stroke or Parkinson's disease.
  • Patients with active urinary tract infection.
  • Patients diagnosed with bladder cancer within the last 2 years.
  • Patients with prostate cancer.
  • Patients who have undergone previous prostate surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Necmettin Erbakan University

Konya, Konya, 42250, Turkey (Türkiye)

Location

Istanbul Medipol University Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (3)

  • Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2.

  • Breda A, Gallioli A, Diana P, Fontana M, Territo A, Gaya JM, Rodriguez-Faba O, Huguet J, Piana A, Verri P, Baboudjian M, Aumatell J, Algaba F, Palou J. The DEpth of Endoscopic Perforation scale to assess intraoperative perforations during transurethral resection of bladder tumor: subgroup analysis of a randomized controlled trial. World J Urol. 2023 Oct;41(10):2583-2589. doi: 10.1007/s00345-022-04052-w. Epub 2022 Jun 4.

  • Gilling PJ, Kennett K, Das AK, Thompson D, Fraundorfer MR. Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol. 1998 Oct;12(5):457-9. doi: 10.1089/end.1998.12.457.

Related Links

MeSH Terms

Conditions

Prostatic Hyperplasia

Interventions

Morcellation

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Minimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Selçuk Güven, Prof. Dr.

    Necmettin Erbakan University

    STUDY DIRECTOR
  • Bülent Erkurt, Prof. Dr.

    Istanbul Medipol University Hospital

    STUDY CHAIR
  • Selim Soytürk, RA

    Necmettin Erbakan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

June 4, 2024

First Posted

June 21, 2024

Study Start

October 8, 2025

Primary Completion

November 14, 2025

Study Completion

November 14, 2025

Last Updated

November 18, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations